Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/1/2019
SIETES contiene 92637 citas

 
 
 1 a 20 de 1647 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Healy D. The Goetzsche affair. Dr. David Healy (blog) 2018:5 de noviembre. [Ref.ID 102892]
2.Enlace a cita original Cita con resumen
Mayor S. Pregabalin and gabapentin become controlled drugs to cut deaths from misuse. BMJ 2018;363:16 de octubre. [Ref.ID 102878]
3.Enlace a cita original Cita con resumen
Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011–2016. National Vital Statistics Reports 2018;67:12 de diciembre. [Ref.ID 102871]
5.Enlace a cita original Cita con resumen
Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults ith chronic sciatica: a randomized clinical trial. JAMA Neurology 2018:15 de octubre. [Ref.ID 102863]
6. Cita con resumen
King MA. Pregabalin and gabapentin associated with depression and suicidal ideation. BMJ 2018;363:29 de noviembre. [Ref.ID 102862]
8.Enlace a cita original Cita con resumen
Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park KT. Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA Intern Med 2018:3 de diciembre. [Ref.ID 102858]
9. Cita con resumen
Schuster RM , Gilman J , Schoenfeld D , Evenden J , Hareli M , Ulysse C , Nip E , Hanly A , Zhang H , Evins E. One month of cannabis abstinence in adolescents and young adults is associated with improved memory. J Clin Psychiatry 2018;79:17m11977. [Ref.ID 102839]
10.Enlace a cita original Cita con resumen
Floyd CN, Warren JB. Opioids out of control. Br J Clin Pharmacol 2018;84:mayo. [Ref.ID 102794]
11.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
12.Tiene citas relacionadas Cita con resumen
El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, Aaron C, King A, Chang A. Characteristics of tianeptine exposures reported to the National Poison Data System — United States, 2000–2017. Morbidity and Mortality Weekly Report 2018;67:3 de agosto. [Ref.ID 102752]
13. Cita con resumen
Anónimo. FDA approves elagolix for endometriosis pain. DIA Daily 2018:25 de julio. [Ref.ID 102722]
15. Cita con resumen
Anónimo. FDA approves first drug to reduce excessive sweating. DIA Daily 2018:1. [Ref.ID 102699]
16.Enlace a cita original Cita con resumen
Corvol J-C, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques A-R, Bourdain F, Brandel J-P, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee P-C, Brice A, Vidailhet M, Elbaz A, for the DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 2018;91:e189-201. [Ref.ID 102695]
17. Cita con resumen
18.Enlace a cita original Cita con resumen
Kioumourtzoglou M-A, Coull BA, O’Reilly EJ, Ascherio A, Weisskopf MG. Association of exposure to diethylstilbestrol during pregnancy with multigenerational neurodevelopmental deficits. JAMA Pediatrics 2018;172:670-7. [Ref.ID 102638]
19.Enlace a cita originalTiene citas relacionadas Cita con resumen
Gill SS, Bai AD. Beta testing the potential link between the alpha antagonist tamsulosin and dementia. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102635]
20.Enlace a cita originalTiene citas relacionadas Cita con resumen
Duan Y, Grady JJ, Albertsen PC, Wu ZH. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102634]
Seleccionar todas
 
 1 a 20 de 1647 siguiente >>